Neuro-oncology
Feature
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
Conference Coverage
Oral drug for brain tumor could change treatment landscape
Vorasidenib was associated with a significant delay in time to disease progression when compared with placebo, in a new study.
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
From the Journals
Study shows higher obesity-related cancer mortality in areas with more fast food
An ecologic study showed a dose-response relationship among measures of food swamp and food desert scores and obesity-related cancer mortality.
Conference Coverage
Expert discusses which diets are best, based on the evidence
The Mediterranean diet is not only helpful for losing weight but also can reduce the risk of various chronic diseases.
From the Journals
Plasma monitoring supports earlier osimertinib treatment in lung cancer patients
More patients met progression-free survival endpoints after shorter stint on gefitinib.
Conference Coverage
Study gives new insight into timing of combo treatment in metastatic NSCLC
Best outcomes came when immunotherapy followed radiotherapy by 1-12 months.
Conference Coverage
First target doesn’t affect survival in NSCLC with brain metastases
Patient outcomes didn’t hinge on whether oncologists treated the brain or lung first.
Commentary
Local therapies show promise for metastatic lung cancer
Local therapy for colorectal cancer with limited liver-only metastases is now established as a path to potentially excellent long-term survival....
Latest News
A single pediatric CT scan raises brain cancer risk
"CT examinations should only be used when necessary, and if they are used, the lowest achievable dose should be applied."
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.